Abbott finalizes acquisition of St. Jude Medical
Abbott’s main focus in vascular care has been stents and related products. Recently, the company developed a strong mitral valve repair called MitraClip. By acquiring St. Jude Medical, Abbott’s cardiovascular care industry will expand in nearly every way; now, Abbott will be among the world’s biggest leaders involved in the broad medical device market industry.
St. Jude is dedicated to various medical devices meant to resolve arrhythmias, heart failure, structural heart, vascular disease and chronic pain. With its product portfolio, Abbott will combine its research in cardiac rhythm management, atrial fibrillation and heart failure, as well as other neurological and cardiovascular specialties, to develop new approaches to heart health.
This is important because cardiovascular disease is among the largest, most serious health challenges around the world. Over 40 percent of U.S. adults are estimated to develop a form of cardiovascular disease by the year 2030.
St. Jude’s portfolio and technologies will help Abbott to improve the health of more people around the world. This is the first time that Abbott will have such an extensive global reach with which to improve patients’ lives.
Organizations in this story
Abbott 100 Abbott Park Rd Lake Bluff, IL - 60044